个人患者档案-前列腺决策支持工具的多中心随机试验
该多中心随机对照试验在392例局限性前列腺癌男性中比较基于网络的P3P决策辅助工具与常规护理对决策冲突的影响,1个月时干预组决策冲突量表评分较对照组显著降低(-5.00,95%CI -9.40至-0.59)。作者认为P3P是局限性前列腺癌男性共享决策的有效辅助工具。
要点
- 1个月决策冲突量表评分干预组10.9±16.7 vs 常规护理组9.9±18.0。
- 多变量模型显示干预组决策冲突显著降低(-5.00,95%CI -9.40至-0.59)。
- 收入、婚姻或伴侣状态、决策状态、咨询次数、临床中心和D'Amico风险分类也是冲突预测因素。
核心结论
- 在这项多中心试验中,决策辅助工具显著降低了决策冲突。
- 其他变量影响决策冲突并改变决策辅助工具的效果,尤其是风险分类、咨询次数和资源。
- P3P是局限性前列腺癌男性共享决策的有效辅助工具。
研究设计与样本
- 随机(1:1)、对照、平行组、非盲试验,在美国4个地区开展。
- 纳入临床局限性前列腺癌且即将进行咨询、能说读英语或西班牙语的男性。
- 共392例男性随机分组,干预组198例、常规护理组194例,分别有152例和153例返回1个月结局。
主要发现
- 1个月决策冲突量表(评分范围0至100)均值±标准差:干预组10.9±16.7 vs 常规护理组9.9±18.0。
- 多变量模型显示干预组决策冲突显著降低(-5.00,95%CI -9.40至-0.59)。
- 其他冲突预测因素包括收入、婚姻或伴侣状态、决策状态、咨询次数、临床中心和D'Amico风险分类。
临床怎么用
- 作者认为P3P是局限性前列腺癌男性共享决策的有效辅助工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We evaluated the efficacy of the web based P3P (Personal Patient Profile-Prostate) decision aid vs usual care with regard to decisional conflict in men with localized prostate cancer. MATERIALS AND METHODS: A randomized (1:1), controlled, parallel group, nonblinded trial was performed in 4 regions of the United States. Eligible men had clinically localized prostate cancer and an upcoming consultation, and they spoke and read English or Spanish. Participants answered questionnaires to report decision making stage, personal characteristics, concerns and preferences plus baseline symptoms and decisional conflict. A randomization algorithm allocated participants to receive tailored education and communication coaching, generic teaching sheets and external websites plus a 1-page summary to clinicians (intervention) or the links plus materials provided in clinic (usual care). Conflict outcomes and the number of consultations were measured at 1 month. Univariate and multivariable models were used to analyze outcomes. RESULTS: A total of 392 men were randomized, including 198 to intervention and 194 to usual care, of whom 152 and 153, respectively, returned 1-month outcomes. The mean ± SD 1-month decisional conflict scale (score range 0 to 100) was 10.9 ± 16.7 for intervention and 9.9 ± 18.0 for usual care. The multivariable model revealed significantly reduced conflict in the intervention group (-5.00, 95% CI -9.40--0.59). Other predictors of conflict included income, marital or partner status, decision status, number of consultations, clinical site and D'Amico risk classification. CONCLUSIONS: In this multicenter trial the decision aid significantly reduced decisional conflict. Other variables impacted conflict and modified the effect of the decision aid, notably risk classification, consultations and resources. P3P is an effective adjunct for shared decision making in men with localized prostate cancer.
引用
- Berry DL, Hong F, Blonquist TM, et al. Decision Support with the Personal Patient Profile-Prostate: A Multicenter Randomized Trial. J Urol. 2017. PMID: 28754540. doi:10.1016/j.juro.2017.07.076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。